1)- Zachary Bloomgarden. Should glucagon-like peptide-1 receptor agonist treatment be withheld in preoperative management?Journal of diabetes. 2023, 15 (9): 712-713
3)- . Blood pressure targets for prevention of cognitive decline in patients with diabetes and hypertension: Design of the Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study.Journal of diabetes. 2023, 15 (12): 1041-1047
5)- Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro. Type 1 diabetes prevention and treatment: Time to think outside the box.Journal of diabetes. 2023, 15 (12): 1107-1108
8)- Joel Hanhart, Sohee Jeon, Raimo Tuuminen. Should patient enrollment criteria for anti-VEGF phase III trials be reconsidered.Journal of diabetes. 2023, 15 (10): 911-912
10)- Ming Shen, Yuanbin Wu, Libing Li, Liyue Zhang, Gang Liu, Rong Wang. CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR-22-3p/DAPK2 Axis.Journal of diabetes. 2023, :
12)- Chenye Jin, Yaxin Lai, Yongze Li, Di Teng, Wenying Yang, Weiping Teng, Zhongyan Shan, . Changes in the prevalence of diabetes and control of risk factors for diabetes among Chinese adults from 2007 to 2017: An analysis of repeated national cross-sectional surveys.Journal of diabetes. 2023, :
13)- Liam Mc Morrow, Frauke Becker, Ruth L Coleman, Hertzel C Gerstein, Lars Rydén, Stefan Schöder, Alastair M Gray, Jose Leal, Rury R Holman, . Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.Journal of diabetes. 2023, :
15)- Xiangyang Liu, Wenjuan Yang, Jianrong Liu, Xinxi Huang, Yujie Fang, Jie Ming, Jingbo Lai, Jianfang Fu, Qiuhe Ji, Li Wang. The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open-label, randomized trial.Journal of diabetes. 2023, :
17)- Takafumi Masuda, Naoto Katakami, Hirotaka Watanabe, Naohiro Taya, Kazuyuki Miyashita, Mitsuyoshi Takahara, Ken Kato, Akio Kuroda, Munehide Matsuhisa, Iichiro Shimomura. Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.Journal of diabetes. 2023, :
18)- Zhiqiang Ning, Guoqiang Ai, Bo Chen, He Yao, Haixiang Cao, Desi Pan, Xianping Lu. Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trials.Journal of diabetes. 2023, :
21)- Ruiqi Yu, Xiaoyu Liu, Ruochen Li, Xinhua Xiao. Ten-year clinical characteristics of patients with early-onset type 2 diabetes: A single-center experience in China.Journal of diabetes. 2023, :
22)- Qiu Yang, Hongyi Cao, Qi Zeng, Bing Fu. Accumulative prediction values of serum thyroid stimulating hormone and visceral adipose tissue for metabolic syndrome in postmenopausal women: A 10-year follow-up study of Chinese population.Journal of diabetes. 2023, :
23)- Ping Yang, Weiwei Xu, Ling Liu, Gangyi Yang. Association of lactate dehydrogenase and diabetic retinopathy in US adults with diabetes mellitus.Journal of diabetes. 2023, :
24)- Dan Zhou, Zhongwen Ye, Zhiqiang Nie, Chaolei Chen, Songyuan Luo, Mengqi Yan, Jiabin Wang, Yingqing Feng. Positive additive interaction effects of age, sex, obesity, and metabolic syndrome on left ventricular dysfunction.Journal of diabetes. 2023, :
27)- Xuee Su, Huibin Huang, Jinqing Lai, Shu Lin, Yinqiong Huang. Long noncoding RNAs as potential diagnostic biomarkers for diabetes mellitus and complications: A systematic review and meta-analysis.Journal of diabetes. 2023, :
28)- Stephanie Vermeulen, Mirjam E A Scheffer-Rath, Martine T P Besouw, Amarens van der Vaart, Martin H de Borst, Annemieke M Boot. Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes.Journal of diabetes. 2023, :
29)- Lía Nattero-Chávez, Jorge Bondía, Héctor F Escobar-Morreale, Manuel Luque-Ramírez. Closed-loop systems in Type 1 diabetes and antitumor necrosis factor alpha therapy: Are currently available algorithms prepared for sudden changes in insulin sensitivity?Journal of diabetes. 2023, :
31)- Camilla Böhme Kristensen, Joseph Chilcot, Sarah E Jackson, Andrew Steptoe, Ruth A Hackett. The impact of a diabetes diagnosis on health and well-being: Findings from the English Longitudinal Study of Ageing.Journal of diabetes. 2023, :
32)- Yaning Chen, Xiaodong Hu, Mingwei Zhao. Clinical and genetic characteristics of maturity-onset diabetes of the young type 13: A systematic review of the literature.Journal of diabetes. 2023, :
33)- Rungroj Krittayaphong, Thanita Boonyapiphat, Arjbordin Winijkul, Gregory Y H Lip. Clinical outcomes of obese and nonobese patients with atrial fibrillation according to associated metabolic abnormalities: A report from the COOL-AF registry.Journal of diabetes. 2023, :
36)- Wenjing Dong, Shiju Yan, Han Chen, Jian Zhao, Zengqiang Zhang, Weijun Gu. Association of remnant cholesterol and newly diagnosed early-onset type 2 diabetes mellitus in Chinese population: A retrospective cross-sectional study.Journal of diabetes. 2023, :
38)- Lin Yang, Yan Shen, Wenxiao Li, Bingbing Zha, Wenjun Xu, Heyuan Ding. Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.Journal of diabetes. 2023, :
39)- Yuying Yang, Jianmin Liu, Stavroula Kousteni. Lipocalin 2-A bone-derived anorexigenic and β-cell promoting signal: From mice to humans.Journal of diabetes. 2023, :
41)- Minmin Wang, Jingyi Liu, Jia Wang, Yinzi Jin, Zhi-Jie Zheng. Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019.Journal of diabetes. 2023, :
42)- Lingyan Chen, Li Wu, Qian Li, Hui Ma, Ting Liu, Jing Li, Baisheng Pan, Yu Hu, Huandong Lin, Xin Gao. Lower urinary albumin-to-creatinine ratio predicted all-cause and cardiovascular mortality in Chinese population with diabetes and prediabetes-The Shanghai Changfeng cohort study.Journal of diabetes. 2023, :
43)- Leigh Perreault, Bryan C Bergman. Out of stock: A brief clinical reference for rough equivalency of glucagon-like peptide-1 (GLP-1) ± glucose-dependent insulinotropic polypeptide (GIP) receptor agonists for A1c and weight reduction in people with type 2 diabetes.Journal of diabetes. 2023, :
44)- Juliana N M Lui, Eric S H Lau, Aimin Yang, Hongjiang Wu, Amy Fu, Vanessa Lau, Kitman Loo, Theresa Yeung, Rebecca Yue, Ronald C W Ma, Alice P S Kong, Risa Ozaki, Andrea O Y Luk, Elaine Y K Chow, Juliana C N Chan. Temporal associations of diabetes-related complications with health-related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults-Joint Asia Diabetes Evaluation (JADE) register (2007-2018).Journal of diabetes. 2023, :
45)- Yufang Liu, Sanbao Chai, Xiaomei Zhang. Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria.Journal of diabetes. 2023, :
46)- Joseph Henson, Melanie J Davies, Emer M Brady, Charlotte L Edwardson, Andrew P Hall, Kamlesh Khunti, Emma Redman, Alex V Rowlands, Jack Sargeant, Thomas Yates. The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes.Journal of diabetes. 2023, :